Korean Drug Co., Ltd.

₩2,780As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:014570Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (4.41%)
Div yield 5.76%
ROE 1.88%
Pharmaceutical Preparations
Beta (5Y) 0.24
PE TTM 20.31
TSR TTM (30.96%)
Mkt cap ₩30.34B
ROIC 2.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,958
6.40%
(53.36%)
Hold 3|1|1|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
68.39
65.26
71.01
72.79
24.52%
12.66%
16.49%
17.11%
Revenue₩B
2.490
2.550
2.685
2.834
12.21%
12.13%
11.93%
15.14%
Peers (US$22.37M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.611
0.172
0.168
EBIT/Intx
0.862
0.767
0.697
Own earn%
1.34
7.97
12.50
Sh yield%
50.74
43.74
41.03
Owners
Insiders/Inst%
9.56
47.15
Short interest%
0.56
SBC / revenue%
2.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
11–19
$1 testx
—
Incr. ROIC%
−3